Subscribe

Sunwels Co.,Ltd. (9229.T)

JPY152.00 +4.00 (+2.70%)
JP JPX Healthcare Medical - Care Facilities
Address 15-13 Ninomiyamachi 920-0067
Kanazawa, JP
CEO Ryotatsu Nawashiro
Website sunwels.jp
IPO 2022-06-27
ISIN JP3324410004

Explore sections of this company profile

Description

Sunwels Co., Ltd. primarily delivers nursing care services, with its operations prominently featuring the "PD house" model. The company runs specialized residential facilities for seniors diagnosed with Parkinson's disease and also manages a Kaatsu training gym. Its extensive service portfolio encompasses daily care, in-home assistance, customized care planning, and home modification services. Additionally, Sunwels oversees various medical-specific establishments. Established in 2006, the company is headquartered in Kanazawa, Japan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY152.00 +4.00 (+2.70%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
300.9K
Beta
-0.03
Float Shares
15.03M
Free Float %
46.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-4.19% -13.68% -26.51% -37.54% -59.33% -48.45% -65.47% -93.77% -80.39% -80.39% -80.39%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
152.00
Ratings Trend (MoM)
Rating 2026-03 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
0.63
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +6.2% Q1'26: +19.3% (vs Q1'25)
  • ✗
    EPS growth Medical - Care Facilities: +19.2%
    -75.5% Q1'26: +149.7% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    -10.7% Q1'26: +0.0% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    -4.4% Q1'26: -0.4% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    -3.8% Q1'26: -0.2% (vs Q1'25)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +2.0% Q1'26: 0.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    45.56× Q1'26: 15.52× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.02) × ERP
WACC = 22% × Ke + 78% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 152.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2023
actual 		Mar 2024
actual 		Mar 2025
actual 		Mar 2026
1 Rev. Ana.
1 EPS Ana. 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana. 		Mar 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
13.24B
est: 13.60B (-2.7%)
20.11B
est: 21.19B (-5.1%)
26.50B
est: 26.84B (-1.3%)
28.30B
28.30B – 28.30B
+5.5% YoY
32.00B
32.00B – 32.00B
+13.1% YoY
34.00B
34.00B – 34.00B
+6.3% YoY
77.50B
77.50B – 77.50B
+127.9% YoY
EBITDA
1.45B
est: 1.58B (-8.5%)
3.09B
est: 2.92B (+5.8%)
2.50B
est: 2.41B (+3.9%)
2.54B
2.54B – 2.54B
+5.5% YoY
2.87B
2.87B – 2.87B
+13.1% YoY
3.05B
3.05B – 3.05B
+6.3% YoY
6.95B
6.95B – 6.95B
+127.9% YoY
EBIT
953.91M
est: 1.05B (-8.9%)
2.27B
est: 1.42B (+60.4%)
1.12B
est: 1.15B (-2.8%)
1.21B
1.21B – 1.21B
+5.5% YoY
1.37B
1.37B – 1.37B
+13.1% YoY
1.45B
1.45B – 1.45B
+6.3% YoY
3.31B
3.31B – 3.31B
+127.9% YoY
Net Income
303.60M
est: 746.06M (-59.3%)
802.00M
est: 2.01B (-60.1%)
-925.00M
est: -454.06M (-103.7%)
-2.40B
-2.40B – -2.40B
-428.6% YoY
-898.39M
-898.39M – -898.39M
+62.6% YoY
-201.08M
-201.08M – -201.08M
+77.6% YoY
9.55B
9.55B – 9.55B
+4,850.0% YoY
SGA
2.02B
est: 2.10B (-3.8%)
2.55B
est: 3.11B (-18.1%)
3.22B
est: 3.67B (-12.5%)
3.87B
3.87B – 3.87B
+5.5% YoY
4.38B
4.38B – 4.38B
+13.1% YoY
4.65B
4.65B – 4.65B
+6.3% YoY
10.61B
10.61B – 10.61B
+127.9% YoY
EPS
10.79
est: 23.47 (-54.0%)
26.60
est: 63.25 (-57.9%)
-29.09
est: -14.00 (-107.8%)
-74.00
-74.00 – -74.00
-428.6% YoY
-27.70
-27.70 – -27.70
+62.6% YoY
-6.20
-6.20 – -6.20
+77.6% YoY
294.50
294.50 – 294.50
+4,850.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-07 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
6.94B
OE per share TTM
221.18
Owner's Yield
105.88%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
94.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 4 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Avantis International Small Cap Equity ETF AVDS 0.00% 1.3K 0.30%
2 iShares Core TOPIX ETF 1475.T 0.00% 17.4K 0.05%
3 Avantis International Small Cap Value ETF AVDV 0.00% 15.9K 0.36%
4 Avantis International Equity ETF AVDE 0.00% 5.8K 0.23%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-502.3K
Shares Outstanding
32.43M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Eiichi Ueno GM of Corporate Division & Director — male
Ryotatsu Nawashiro Chairman, President & Chief Executive Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities